Received Jul 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
now has low titers; This non-serious case was reported by a other health professional via call center representative and described the occurrence of therapy non-responder in a patient who received HBV (Engerix B) for prophylaxis. On an unknown date, the patient received Engerix B. On an unknown date, an unknown time after receiving Engerix B, the patient experienced therapy non-responder (Verbatim: now has low titers). The outcome of the therapy non-responder was not applicable. Additional Information: GSK Receipt Date : 01-JUL-2025 Pharmacy student called and reports a patient received the complete schedule for Engerix-B in 2021 and now has low titers.